Loading organizations...

§ Private Profile · London, United Kingdom
Phytoform Labs is a technology company.
Phytoform Labs operates as a biotechnology firm focused on advancing crop genetics through an innovative platform. The company employs its proprietary CRE.AI.TIVE AI technology combined with precision breeding techniques, including gene editing, to significantly accelerate plant development. This sophisticated approach enables the engineering of resilient, or "future-proof," crops designed to thrive in challenging conditions, effectively shortening traditional breeding cycles for vital agricultural products.
The company was established in 2017 by Dr. Will Pelton and Dr. Nicolas Kral. Their entrepreneurial journey was driven by a shared, profound insight: crop genetics offers a fundamental solution to many pressing global challenges related to food security and environmental sustainability. Both founders brought a deep understanding of biological innovation and technological application to their vision for agricultural improvement.
Phytoform Labs' technology assists plant breeders by providing efficient methods for developing enhanced crop varieties. The company is committed to fostering a more sustainable and robust food system globally. Its long-term vision is centered on mitigating the detrimental environmental effects of conventional agriculture by systematically unlocking and leveraging the inherent genetic potential present within various plant species.
Phytoform Labs has raised $6.3M across 2 funding rounds.
Phytoform Labs has raised $6.3M in total across 2 funding rounds.
Phytoform Labs is a biotechnology company founded in 2017 that develops resilient, climate-adapted crops using AI-driven predictive biology and precision genome editing.[2][1][3] It builds CRE.AI.TIVE™, a proprietary platform combining sequence-to-expression AI modeling with protoplast-based CRISPR-Cas editing to create novel, nature-identical traits like net-yield boosts, climate resilience, and reduced food waste in months at a fraction of traditional breeding costs.[1][3][4] The company serves seed producers, supply chain owners, and vertical farmers by delivering validated genetic patents and alleles for elite crop varieties, targeting problems like agricultural supply chain inefficiency, input overuse, and climate vulnerabilities.[1][3][4] With $5.75M raised and field trials underway (e.g., compact "tiny tomatoes" yielding 5x per area and non-browning potatoes), Phytoform shows strong growth momentum, scaling across species from its Rothamsted Research base.[2][3][4][5]
Phytoform Labs emerged from the PhD research of co-founders CEO William Pelton and CTO Nicolas Kral at Imperial College London, sparked by their shared interest in using genetics to enhance agricultural sustainability and resilience.[3][6] Founded in 2017 and headquartered in Harpenden, UK (near Rothamsted Research and also linked to Salisbury), the company addressed gaps in crop innovation amid climate challenges and outdated breeding methods.[2][5][6] Early traction came from developing CRE.AI.TIVE™, inspired by their academic work, enabling rapid trait design without linkage drag; pivotal moments include Greentown Labs membership, patent filings in biotechnology and cell biology, and UK field trials post-Genetic Technology (Precision Breeding) Act.[3][4][2][7] The duo's vision—to minimize agriculture's environmental impact while improving food health—drove multidisciplinary hiring of genome engineers, data scientists, and agronomists.[6][8][7]
Phytoform stands out in ag-biotech through these key strengths:
Phytoform rides the climate-resilient agriculture wave, accelerating plant evolution amid global warming, droughts, and supply chain waste—key as agriculture must cut emissions while adapting.[3][1][6] Timing aligns with regulatory shifts like the UK's Precision Breeding Act, enabling UK trials and sales of gene-edited crops without GMO labels.[4] Market tailwinds include rising demand for low-input, vertical/indoor farming and biologicals over synthetics, plus AI-biotech convergence (e.g., vs. competitors like HELM Agro).[2][3][4] It influences the ecosystem by unlocking native genetic diversity, reducing resource needs, boosting food security, and providing blueprints to seed firms, potentially transforming staples like tomatoes and potatoes.[1][4][3]
Phytoform is poised for expansion with secondary UK legislation unlocking commercial sales, more field trials, and platform scaling to new species/challenges like supply chain efficiency.[4][1] Trends like AI-genomics integration, precision breeding deregulation, and vertical farming growth will propel it, amplifying impact on sustainable yields and resilience.[3][4] Its influence may evolve from trait innovator to ecosystem enabler, partnering widely to deploy "future-proof" crops—reinforcing its mission to redefine ag-sustainability from the DNA up.[1][6][8]
Phytoform Labs has raised $6.3M across 2 funding rounds. Most recently, it raised $6.0M Seed in December 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2021 | $6M Seed | Eniac Ventures | 20VC, Activumsg, Data Tech Fund, DAY ONE Ventures, GFT Ventures, Lightspeed Venture Partners, Pareto Holdings, Point Nine Capital, Stride VC, TrueSight Ventures, Azeem Azhar, Chris Murphy, Marc Mccabe, Richard Fearn, IAN Hogarth, Jeff Dean, Rick Bernstein, Backed, Fine Structure Ventures, FTW Ventures, Pale Blue DOT, Refactor Capital, Wireframe Ventures | Announced |
| Jun 1, 2021 | $250K Seed | — | Astanor Ventures, FTW Ventures, TET Ventures | Announced |
Phytoform Labs has raised $6.3M in total across 2 funding rounds.
Phytoform Labs's investors include ENIAC Ventures, 20VC, ActivumSG, Data Tech Fund, Day One Ventures, GFT Ventures, Lightspeed Venture Partners, Pareto Holdings, Point Nine Capital, Stride VC, TrueSight Ventures, Azeem Azhar.